Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia
by Huber, Henriette (Author)
, Edenhofer, Simone (Author)
, von Tresckow, Julia (Author)
, Robrecht, Sandra (Author)
, Zhang, Can (Author)
, Tausch, Eugen (Author)
, Schneider, Christof (Author)
, Bloehdorn, Johannes (Author)
, Fürstenau, Moritz (Author)
, Dreger, Peter (Author)
, Ritgen, Matthias (Author)
, Illmer, Thomas (Author)
, Illert, Anna L. (Author)
, Dürig, Jan (Author)
, Böttcher, Sebastian (Author)
, Niemann, Carsten U. (Author)
, Kneba, Michael (Author)
, Fink, Anna-Maria (Author)
, Fischer, Kirsten (Author)
, Döhner, Hartmut (Author)
, Hallek, Michael (Author)
, Eichhorst, Barbara (Author)
, Stilgenbauer, Stephan (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource